Skip to main content
TipRanks
Go Ultimate75% OFF

Intellia Therapeutics (NTLA) Q2 2023 Earnings Report

4,936 Followers

NTLA Q2 2023 EPS Results

Actual EPS
-$1.40
Consensus EPS
-$1.32
Beat/Miss
Missed by -$0.08
One Year Ago EPS
-$1.33

NTLA Q2 2023 Revenue Results

Actual Revenue
$13.59M
Expected Revenue
$12.08M
Beat/Miss
Beat by +$1.51M
YoY Revenue Growth
-3.11%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/03/2023
Time
Before Open
Conference Call
Thursday, August 3, 2023
NTLA Upcoming Earnings

Intellia Therapeutics's next earnings date is estimated for February 25, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

NTLA Q2 2023 Earnings Call
0:00 / 0:00

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

NTLA Earnings History

NTLA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 25, 20272026 (Q4)-0.79--0.83――
Nov 05, 20262026 (Q3)-0.80-0.91-0.921.09% (+0.01)
Aug 06, 20262026 (Q2)-0.80-0.80-0.9818.37% (+0.18)
May 11, 20262026 (Q1)-0.91-0.81-1.126.36% (+0.29)
Feb 26, 20262025 (Q4)-0.95-0.83-1.2734.65% (+0.44)
Nov 06, 20252025 (Q3)-1.00-0.92-1.3431.34% (+0.42)
Aug 07, 20252025 (Q2)-1.02-0.98-1.5235.53% (+0.54)
May 08, 20252025 (Q1)-1.28-1.10-1.121.79% (+0.02)
Feb 27, 20252024 (Q4)-1.33-1.27-1.4613.01% (+0.19)
Nov 07, 20242024 (Q3)-1.39-1.34-1.382.90% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed